top of page

PROGRAMME

Wed

Wednesday 19 March

12:30-13:30
Registration

13.30-14.30
Opening keynote
Chair: François Moreau Gaudry, Oumeya Adjali

INV01  TBC, Paul Ehrlich Insitute, Langen

TBC

14.30-16.30 
Session 1: Advances and challenges for gene editing technology
Chairs:

INV02:  

 

INV03:  

OR01, OR02, OR03, OR04

15:30-17:00
Coffee Break

17.00-19.00
Session 2: Preclinical and clinical gene editing for gene therapy

Chairs: 

 

INV04  

INV05  

OR05, OR06, OR07, OR08

20:00
Party at Mama Shelter

Thu

Thursday 20 March

08:30-09:00
Registration 

09.00-10.30
Session 3: Cancer therapy and targeting
Chair: 

INV05  

INV06 

 

OR05, OR06

10:30-11:00
Coffee Break

11.00-12.30
Session 4: Immunotherapy and CAR-T cells
Chair: 

INV07  

INV08  

 

OR07, OR08

12:30-13:30
Lunch

13:30-14:30
Poster session

14.30-16.15 
Session 5: Gene therapy for genetic diseases
Chair: 

INV09  

INV10  

OR09, OR10, OR11

16:15-16:45
Coffee Break

16.45-18.30

Session 6: Disease model : IPSc and organoids cell therapy

Chair: 

INV11 

INV12 

OR12, OR13, OR14

18:30-20:00
Poster session 2

Fri

Friday 21 March

08:30-09:00
Registration 

09.00-11.00
Session 7: AAV and lentiviral vectors for gene therapy
Chair: 

INV13  

INV14  

 

OR15, OR16, OR17, OR18

11:00-11:30
Coffee Break

11.30-13.00
Session 8: Non-viral vector / nanotechnology for gene editing
Chair: 

INV15  

INV16  

OR19, OR20

13:00-14:00
Lunch and posters

14.00-16.00 
Session 9: Innovative approaches
Chair: 

INV17  

INV18  

OR21, OR22, OR23, OR24

16.00-16.45

Session 10: Closing keynote

Chair: 

INV19

 

16:45-17:00
Poster and oral presentation awards

bottom of page